Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2024)Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.
Sectors & IndustriesHealthcare
Sector: Healthcare
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| QLI | QILIAN INTERNATIONAL HOLDING GROUP LTD | China | $26.10M | 35,750,000 | 0.08% | 0.00% | ||
| STRO | SUTRO BIOPHARMA INC | United States | $259.13M | 62,441,963 | 78.85% | 21.15% | Net Selling | Net Selling |
| SVRA | SAVARA INC | United States | $643.27M | 138,188,891 | 32.26% | 67.74% | Net Buying | Net Selling |
| NXTC | NEXTCURE INC | United States | $46.16M | 27,973,289 | 47.70% | 50.08% | ||
| CERS | CERUS CORP | United States | $319.86M | 184,890,071 | 76.73% | 5.84% | Net Selling | Net Selling |
| RXRX | RECURSION PHARMACEUTICALS INC | United States | $2.04B | 237,663,668 | 75.32% | 24.68% | Net Selling | Net Selling |
| ACET | ADICET BIO INC | United States | $120.77M | 82,153,984 | 40.62% | 19.50% | Net Buying | |
| ATHA | ATHIRA PHARMA INC | United States | $81.25M | 38,326,652 | 57.11% | 31.41% | Net Buying | |
| PNTG | PENNANT GROUP INC | United States | $680.24M | 30,045,760 | 85.34% | 8.91% | Net Buying | Net Buying |
| NBTX | NANOBIOTIX SA | France | $311.08M | 47,133,328 | 19.67% | 0.00% | ||
| AVIR | ATEA PHARMACEUTICALS INC | United States | $327.40M | 84,164,545 | 65.45% | 25.19% | Net Selling | |
| ABEO | ABEONA THERAPEUTICS INC | United States | $114.89M | 27,355,037 | 25.74% | 74.26% | Net Buying | Net Buying |
| LPTX | LEAP THERAPEUTICS INC | United States | $71.17M | 25,600,137 | 12.25% | 87.75% | ||
| NVNO | ENVVENO MEDICAL CORP | United States | $66.65M | 13,330,000 | 27.51% | 72.49% | Net Buying | Net Buying |
| LSTA | LISATA THERAPEUTICS INC | United States | $24.51M | 8,307,433 | 0.84% | 99.16% | Net Selling | |
| COGT | COGENT BIOSCIENCES INC | United States | $722.84M | 95,613,396 | 88.56% | 11.44% | Net Buying | Net Buying |
| PHR | PHREESIA INC | United States | $1.21B | 56,387,472 | 76.62% | 23.38% | Net Selling | Net Selling |
| TARA | PROTARA THERAPEUTICS INC | United States | $61.77M | 20,589,976 | 12.01% | 87.99% | Net Selling | Net Selling |
| BNTC | BENITEC BIOPHARMA INC | Australia | $23.98M | 2,592,434 | 46.20% | 37.31% | ||
| NRIX | NURIX THERAPEUTICS INC | United States | $664.03M | 49,150,794 | 84.43% | 15.57% | Net Selling | Net Selling |
| VIR | VIR BIOTECHNOLOGY INC | United States | $1.28B | 136,058,680 | 62.26% | 37.74% | Net Selling | Net Selling |
| EKSO | EKSO BIONICS HOLDINGS INC | United States | $24.54M | 18,174,426 | 4.27% | 95.73% | Net Selling | |
| EXAI | EXSCIENTIA PLC | United Kingdom | $579.49M | 125,702,396 | 24.77% | 0.00% | ||
| SABS | SAB BIOTHERAPEUTICS INC | United States | $36.99M | 9,225,494 | 40.51% | 59.49% | Net Buying | |
| TARO | TARO PHARMACEUTICAL INDUSTRIES LTD | Israel | $1.59B | 37,587,231 | 12.90% | 50.73% | ||
| PRGO | PERRIGO CO PLC | Ireland | $4.19B | 136,320,433 | 61.54% | 38.46% | Net Buying | Net Buying |
| VRCA | VERRICA PHARMACEUTICALS INC | United States | $339.35M | 42,418,553 | 41.10% | 58.90% | Net Buying | |
| XENE | XENON PHARMACEUTICALS INC | Canada | $3.06B | 75,468,883 | 95.40% | 3.29% | Net Selling | Net Selling |
| MGRM | MONOGRAM ORTHOPAEDICS INC | United States | $59.47M | 31,633,995 | 0.45% | 23.64% | ||
| ARTL | ARTELO BIOSCIENCES INC | United States | $4.33M | 3,227,700 | 0.76% | 25.83% | ||
| PASG | PASSAGE BIO INC | United States | $81.73M | 55,598,796 | 43.60% | 56.40% | Net Buying | Net Selling |
| KRON | KRONOS BIO INC | United States | $61.30M | 60,094,409 | 44.51% | 42.51% | Net Buying | Net Selling |
| VRAX | VIRAX BIOLABS GROUP LTD | United Kingdom | $1.45M | 1,811,540 | 7.37% | 0.00% | ||
| CGEM | CULLINAN THERAPEUTICS INC | United States | $1.14B | 43,065,645 | 48.27% | 51.73% | Net Selling | Net Selling |
| SUPN | SUPERNUS PHARMACEUTICALS INC | United States | $1.59B | 54,974,254 | 45.35% | 54.65% | Net Selling | Net Selling |
| LVTX | LAVA THERAPEUTICS NV | Netherlands | $81.23M | 26,289,087 | 22.20% | 0.00% | ||
| ACST | ACASTI PHARMA INC | Canada | $25.94M | 9,399,404 | 6.08% | 64.72% | Net Buying | |
| VXRT | VAXART INC | United States | $122.57M | 173,861,684 | 9.16% | 69.71% | Net Selling | Net Selling |
| AZTR | AZITRA INC | United States | $6.22M | 28,804,643 | 0.16% | 55.13% | Net Buying | Net Buying |
| PRQR | PROQR THERAPEUTICS NV | Netherlands | $166.81M | 84,248,384 | 21.83% | 0.00% | ||
| KTTA | PASITHEA THERAPEUTICS CORP | United States | $8.01M | 1,042,415 | 2.22% | 97.78% | Net Buying | |
| VCEL | VERICEL CORP | United States | $2.34B | 48,601,736 | 91.15% | 8.85% | Net Selling | Net Selling |
| CBUS | CIBUS INC | United States | $437.96M | 24,687,767 | 14.04% | 85.96% | Net Buying | |
| CRBU | CARIBOU BIOSCIENCES INC | United States | $319.72M | 90,317,771 | 76.47% | 8.74% | Net Buying | |
| RLMD | RELMADA THERAPEUTICS INC | United States | $106.51M | 30,174,202 | 45.13% | 3.43% | Net Buying | |
| WRBY | WARBY PARKER INC | United States | $1.76B | 118,862,327 | 48.64% | 51.36% | Net Selling | Net Selling |
| FEMY | FEMASYS INC | United States | $26.89M | 22,220,718 | 6.38% | 8.01% | ||
| CLVR | CLEVER LEAVES HOLDINGS INC | United States | $4.05M | 1,754,795 | 1.09% | 98.91% | Net Selling | Net Selling |
| ADMA | ADMA BIOLOGICS INC | United States | $2.04B | 231,809,197 | 72.97% | 24.19% | Net Selling | Net Selling |
| TKNO | ALPHA TEKNOVA INC | United States | $73.48M | 40,823,387 | 13.78% | 83.29% | Net Buying | |
| EMBC | EMBECTA CORP | United States | $821.22M | 57,670,209 | 95.98% | 1.52% | Net Selling | Net Selling |
| ENTX | ENTERA BIO LTD | Israel | $88.03M | 35,785,309 | 11.35% | 3.76% | Net Buying | |
| ALDX | ALDEYRA THERAPEUTICS INC | United States | $223.99M | 59,414,489 | 59.11% | 33.90% | Net Selling | Net Buying |
| IPA | IMMUNOPRECISE ANTIBODIES LTD | Canada | $33.95M | 26,315,260 | 6.56% | 0.00% | ||
| NAUT | NAUTILUS BIOTECHNOLOGY INC | United States | $343.23M | 125,265,015 | 40.64% | 59.36% | Net Buying | Net Buying |
| PTPI | PETROS PHARMACEUTICALS INC | United States | $4.39M | 6,875,814 | 1.70% | 84.23% | ||
| NVRO | NEVRO CORP | United States | $359.57M | 36,728,648 | 73.26% | 26.74% | Net Selling | Net Selling |
| NKTX | NKARTA INC | United States | $440.42M | 70,467,620 | 53.86% | 46.14% | Net Buying | Net Buying |
| CELC | CELCUITY INC | United States | $512.53M | 30,453,120 | 52.40% | 15.32% | Net Selling | Net Selling |
| SYRS | SYROS PHARMACEUTICALS INC | United States | $131.48M | 26,453,891 | 46.94% | 53.06% | Net Buying | Net Selling |
| MACK | MERRIMACK PHARMACEUTICALS INC | United States | $219.48M | 14,516,170 | 23.49% | 76.51% | Net Buying | |
| ERAS | ERASCA INC | United States | $320.71M | 173,358,966 | 39.95% | 49.54% | Net Buying | |
| ESPR | ESPERION THERAPEUTICS INC | United States | $414.92M | 189,460,293 | 37.89% | 20.74% | Net Selling | |
| EPIX | ESSA PHARMA INC | Canada | $276.05M | 44,238,147 | 73.10% | 26.90% | Net Buying | Net Buying |
| GDTC | CYTOMED THERAPEUTICS LTD | Singapore | $24.58M | 11,540,000 | 0.04% | 57.45% | ||
| SLNO | SOLENO THERAPEUTICS INC | United States | $1.50B | 33,411,329 | 20.77% | 79.23% | Net Buying | Net Selling |
| PTIX | PROTAGENIC THERAPEUTICS INC | United States | $5.97M | 4,435,132 | 2.55% | 1.03% | Net Buying | |
| XWEL | XWELL INC | United States | $7.61M | 4,183,435 | 1.65% | 98.35% | Net Buying | |
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | China | $82.65M | 55,102,954 | 12.92% | 0.00% | ||
| CMPX | COMPASS THERAPEUTICS INC | United States | $220.14M | 137,589,171 | 62.59% | 12.24% | Net Buying | |
| ANAB | ANAPTYSBIO INC | United States | $639.53M | 27,318,644 | 41.94% | 58.06% | Net Selling | Net Selling |
| LFST | LIFESTANCE HEALTH GROUP INC | United States | $2.62B | 382,287,766 | 32.64% | 67.36% | Net Selling | Net Selling |
| ELYM | ELIEM THERAPEUTICS INC | United States | $234.51M | 27,719,409 | 60.80% | 23.57% | Net Buying | |
| THRD | THIRD HARMONIC BIO INC | United States | $484.50M | 40,714,399 | 73.29% | 26.71% | Net Buying | Net Buying |
| RDNT | RADNET INC | United States | $4.08B | 73,880,145 | 64.36% | 35.64% | Net Selling | |
| QNCX | QUINCE THERAPEUTICS INC | United States | $41.05M | 43,215,233 | 15.43% | 84.57% | Net Buying | |
| SNPX | SYNAPTOGENIX INC | United States | $4.96M | 1,085,334 | 79.75% | 20.25% | ||
| AONC | AMERICAN ONCOLOGY NETWORK INC | United States | $126.79M | 35,716,466 | 0.17% | 19.59% | Net Selling | Net Buying |
| CDTX | CIDARA THERAPEUTICS INC | United States | $55.47M | 4,561,751 | 61.60% | 38.40% | Net Selling | Net Selling |
| ADIL | ADIAL PHARMACEUTICALS INC | United States | $6.08M | 4,054,861 | 5.41% | 94.59% | Net Buying | |
| ACHV | ACHIEVE LIFE SCIENCES INC | United States | $158.31M | 34,341,303 | 7.94% | 27.71% | Net Buying | Net Selling |
| VRNA | VERONA PHARMA PLC | United Kingdom | $1.20B | 648,654,174 | 10.40% | 55.71% | Net Selling | Net Selling |
| HSCS | HEART TEST LABORATORIES INC | United States | $5.77M | 65,561,630 | 1.84% | 1.37% | ||
| ABOS | ACUMEN PHARMACEUTICALS INC | United States | $201.87M | 60,079,778 | 63.98% | 16.58% | Net Buying | |
| XGN | EXAGEN INC | United States | $27.06M | 17,235,751 | 36.96% | 63.04% | Net Selling | Net Selling |
| NUVB | NUVATION BIO INC | United States | $711.90M | 219,046,219 | 50.10% | 49.90% | Net Buying | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | United States | $4.37B | 21,311,526 | 22.67% | 77.33% | Net Buying | Net Buying |
| XTNT | XTANT MEDICAL HOLDINGS INC | United States | $105.48M | 130,216,541 | 40.30% | 59.70% | Net Selling | |
| QTTB | Q32 BIO INC | United States | $323.99M | 11,942,129 | 47.15% | 52.85% | Net Selling | Net Selling |
| ONVO | ORGANOVO HOLDINGS INC | United States | $9.28M | 10,040,074 | 4.53% | 95.47% | Net Selling | |
| AFMD | AFFIMED NV | Germany | $79.94M | 15,227,463 | 100.00% | 0.00% | ||
| RGNX | REGENXBIO INC | United States | $760.51M | 49,255,966 | 76.15% | 23.85% | Net Selling | Net Buying |
| CDNA | CAREDX INC | United States | $772.40M | 52,083,792 | 78.55% | 21.45% | Net Selling | Net Selling |
| AYTU | AYTU BIOPHARMA INC | United States | $18.21M | 5,567,597 | 5.65% | 94.35% | Net Buying | |
| BCYC | BICYCLE THERAPEUTICS PLC | United Kingdom | $979.21M | 42,779,030 | 54.60% | 45.40% | Net Selling | Net Selling |
| RCM | R1 RCM INC | United States | $5.09B | 421,255,230 | 47.62% | 52.38% | Net Selling | Net Selling |
| PRAX | PRAXIS PRECISION MEDICINES INC | United States | $645.77M | 13,238,349 | 40.09% | 59.91% | Net Buying | Net Selling |
| APLS | APELLIS PHARMACEUTICALS INC | United States | $5.10B | 121,365,555 | 74.88% | 25.12% | Net Buying | Net Selling |
| BLFS | BIOLIFE SOLUTIONS INC | United States | $899.44M | 46,030,886 | 58.87% | 41.13% | Net Buying | Net Selling |
| OMGA | OMEGA THERAPEUTICS INC | United States | $108.10M | 55,154,985 | 57.75% | 42.25% | Net Selling |
Healthcare Industries
| Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 680 | -1.62% | -2.51% | -3.52% | -21.05% | 6.42x | 5.91x | +20.97% | +3.56% | -33.88% | +84.90% | Strong Buy | ||
| 66 | +5.11% | +7.27% | +4.18% | +9.23% | 37.39x | 4.36x | -13.51% | +6.44% | +11.47% | +3.98% | Buy | ||
| 17 | -0.53% | +1.82% | +3.59% | +14.38% | 31.93x | 6.33x | +33.48% | +8.06% | +14.18% | +12.79% | Buy | ||
| 90 | -0.72% | -1.27% | +0.66% | -6.21% | -3.15x | 2.17x | +11.81% | +3.11% | +6.07% | +34.14% | Buy | ||
| 12 | +0.39% | +3.48% | +3.54% | +2.41% | 25.16x | 3.02x | +15.17% | +4.73% | +11.77% | +13.27% | Buy | ||
| 59 | -1.02% | -2.32% | -6.09% | -23.97% | 12.79x | 3.34x | +7.06% | +2.44% | +6.04% | +33.12% | Buy | ||
| 51 | +0.10% | +3.37% | +1.26% | +10.73% | 39.75x | 4.47x | -95.44% | +6.74% | +14.01% | +14.51% | Buy | ||
| 153 | -0.47% | -1.92% | -4.16% | -14.44% | 29.79x | 3.92x | +7.18% | +5.22% | +7.62% | +21.81% | Buy | ||
| 9 | +0.59% | +3.79% | -0.11% | +28.86% | 26.83x | 110.00x | -10.56% | +3.43% | +19.55% | +9.31% | Buy | ||
| 56 | +0.54% | +1.52% | -0.53% | -8.80% | 58.36x | 3.57x | +11.29% | +7.72% | +10.10% | +19.62% | Buy |
Healthcare Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.